Coronary/Structural Heart

Novocardia™ Launches Groundbreaking, Value-Based Heart Failure Management Program to Improve Patient Outcomes and Reduce Hospitalizations

The heart failure program is a new model for cardiology practices in managing heart failure, starting with patients in Northeast Florida NEW YORK, May 17, 2022 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care platform, has launched an innovative heart failure program that combines individualized health coaching and remote patient monitoring to improve […]

HealthTech Arkansas and MedAxiom Collaborate to Launch HeartX, A Cardiovascular Accelerator Program

LITTLE ROCK, Ark., May 17, 2022 /PRNewswire/ — HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market. Applications for the 2022 HeartX cohort are now open, and companies […]

HFSA Releases Position Paper on The Impact of Healthcare Disparities on Patients with Heart Failure

ROCKVILLE, Md.  , May 17, 2022 /PRNewswire/ —  A new position paper published today by the Heart Failure Society of America (HFSA) outlines disparities in healthcare that affect patients with heart failure, including race and ethnicity, socioeconomic factors, and social determinants of health. The statement also presents actions that can be taken to […]

Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)

AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary vasculature, which are key features of the pathophysiology of PAH PAH is an area of high unmet need, and currently approved therapies are limited by acting primarily through vasodilation These Phase 1 results show that […]

Cytokinetics Provides Regulatory Update Related to New Drug Application for Omecamtiv Mecarbil

FDA Plans to Convene Advisory Committee Meeting SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the Company recently participated in a mid-cycle communication meeting with the U.S. Food & Drug Administration (FDA) and was informed that the Agency plans to convene an […]

Huma and Tamer bring digital ‘hospital at home’ platform to the Kingdom of Saudi Arabia to tackle diabetes and cardiovascular disease

LONDON, May 16, 2022 /PRNewswire/ — Tamer, the Middle-East’s leading healthcare distribution company, has agreed a 5-year deal to bring Huma’s market leading technology platform to power ‘hospitals at home’ with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health programme will begin with support for […]

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

PDUFA action date set for October 8, 2022 Company preparing for Q4 commercial launch, if approved BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient […]

Medtronic receives FDA approval for latest generation drug-eluting coronary stent system

The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx […]

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions BOSTON, May 12, 2022 /PRNewswire/ —  Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced today that its Biofourmis Care solution has been selected by the American […]

VESTECK, Inc. Delivers multiple presentations at Charring Cross International Symposium

WEST CHESTER, Pa., May 11, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium. “Charring Cross” (CX), held annually in London, UK, is considered one of the premier global Vascular/Endovascular symposiums. Key Opinion Leaders from around the world assemble to […]